Severe Asthma Digital Marketing Trends Report 2022 Featuring Sanofi, Regeneron, Genentech, Novartis, GSK, AstraZeneca, Amgen, & Teva

DUBLIN, Nov. 21, 2022 /PRNewswire/ — The “Digital Marketing Trends in Severe Asthma” report has been added to ResearchAndMarkets.com’s offering. Sanofi/Regeneron’s Dupixent.com achieved the highest traffic across branded severe asthma patient sites in the US from July 2021 to June 2022,…

Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.


*